[Form 4] IBEX Ltd Insider Trading Activity

Rhea-AI Filing Summary

IBEX Ltd Form 4 summary: The filing by Bruce Neil Dawson reports transactions in IBEX Ltd (IBEX) on 09/16/2025. The reporting person executed an acquisition of 8,114 common shares (code M) at a reported price of $19.00, and two sales of common shares the same date: 8,114 shares sold at a weighted average price of $38.14 and 765 shares sold at a reported price of $38.2903. Following the reported transactions, the filing shows beneficial ownership levels of 13,371, 5,257, and 4,492 shares on the respective lines. The seller notes the sales were executed in multiple trades at prices ranging from $38.2901 to $38.35 and offers to provide further breakdowns on request. The form is signed by an attorney-in-fact, Lisa Lenstrohm, dated 09/17/2025.

Positive

• Timely disclosure of insider transactions for 09/16/2025, including purchase and sales lines
• Sales price transparency with weighted-average price and disclosed trade price range
• Willingness to provide per-trade details on request, improving transparency

Negative

• Net reduction in direct holdings shown on the sales lines (beneficial ownership decreases to 5,257 and 4,492 shares on subsequent lines)
• No context provided about the purpose of the acquisition or sales (e.g., option exercise, tax sale, or other reason) within the filing

Insights

Securities Analyst

TL;DR: Form 4 shows same-day acquisition and sales by an officer, with weighted-average sale pricing disclosed and an offer to provide trade-level details.

The filing documents a non-derivative purchase of 8,114 common shares (code M) at $19.00 and subsequent sales of 8,114 and 765 shares at reported prices near $38.14 and $38.2903 on 09/16/2025. The seller discloses the sales were executed in multiple trades at prices between $38.2901 and $38.35 and confirms willingness to provide exact per-trade quantities on request. For investors, the form is a routine Section 16 disclosure that improves transparency about insider trading activity; it does not include additional context such as prior holdings, motivation, or company-level events.

Corporate Governance Expert

TL;DR: Officer-level Form 4 filing properly discloses acquisitions and dispositions and includes an explanatory remark on execution prices.

The report is filed by an officer of IBEX and lists the officer's title. It records both acquisition and disposition lines and includes the required explanatory remark that sales were executed in multiple trades with a stated price range. The form is signed by an attorney-in-fact, satisfying procedural signature requirements. The disclosure appears complete within the scope of the form; no corrective amendment or missing fields are evident from the provided content.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Dawson Bruce Neil

(Last) (First) (Middle)

C/O IBEX LIMITED

1717 PENNSYLVANIA AVENUE NW, SUITE 825

(Street)

WASHINGTON DC 20006

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IBEX Ltd [ IBEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Sales and CS Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/16/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	09/16/2025		M		8,114	A	$19	13,371	D
Common Shares	09/16/2025		S		8,114	D	$38.14	5,257	D
Common Shares	09/16/2025		S		765	D	$38.2903(1)	4,492	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction was executed in multiple trades at prices ranging from $38.2901 to $38.35; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Remarks:

	Lisa Lenstrohm, Attorney-in-Fact	09/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions does the IBEX Form 4 (09/16/2025) report?

The filing reports an acquisition of 8,114 common shares at $19.00 and sales of 8,114 and 765 common shares at weighted-average prices around $38.14 and $38.2903 on 09/16/2025.

Who is the reporting person on this Form 4 for IBEX (IBEX)?

The reporting person is Bruce Neil Dawson, listed as an officer (Chief Sales and CS Officer) of IBEX Ltd.

Do the sales include per-trade price details?

The filing states the sales were executed in multiple trades at prices ranging from $38.2901 to $38.35 and offers to provide full per-trade details on request.

Was the Form 4 signed and dated?

Yes. The form is signed by attorney-in-fact Lisa Lenstrohm and dated 09/17/2025.

What are the post-transaction beneficial ownership figures reported?

The form shows beneficial ownership amounts of 13,371, 5,257, and 4,492 shares on the respective lines following the reported transactions.